These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35384179)

  • 1. Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors.
    García-Domínguez L; Navas P; Verdugo MÁ; Arias VB; Gómez LE
    J Appl Res Intellect Disabil; 2022 Sep; 35(5):1109-1118. PubMed ID: 35384179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross-sectional survey.
    Perry BI; Cooray SE; Mendis J; Purandare K; Wijeratne A; Manjubhashini S; Dasari M; Esan F; Gunaratna I; Naseem RA; Hoare S; Chester V; Roy A; Devapriam J; Alexander R; Kwok HF
    J Intellect Disabil Res; 2018 Feb; 62(2):140-149. PubMed ID: 29349928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of psychotropic medication and factors associated with antipsychotic treatment in adults with intellectual disabilities: a cross-sectional, epidemiological study in Germany.
    Koch AD; Dobrindt J; Schützwohl M
    J Intellect Disabil Res; 2021 Feb; 65(2):186-198. PubMed ID: 33393123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic medication use in adolescents with intellectual disability living in the community.
    Doan T; Ware R; McPherson L; van Dooren K; Bain C; Carrington S; Einfeld S; Tonge B; Lennox N
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):69-76. PubMed ID: 23929635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structured Medication Review to Improve Pharmacotherapy in People with Intellectual Disability and Behavioural Problems.
    Scheifes A; Egberts TC; Stolker JJ; Nijman HL; Heerdink ER
    J Appl Res Intellect Disabil; 2016 Jul; 29(4):346-55. PubMed ID: 25882186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
    Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
    J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic drug use among people with intellectual disability before and after deinstitutionalization.
    Nøttestad JA; Linaker OM
    J Intellect Disabil Res; 2003 Sep; 47(Pt 6):464-71. PubMed ID: 12919197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007.
    Hsu SW; Chiang PH; Chang YC; Lin JD; Tung HJ; Chen CY
    Res Dev Disabil; 2014 Feb; 35(2):364-72. PubMed ID: 24333807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of psychotropic medications in adults with intellectual disability: A systematic review and meta-analysis.
    Song M; Rubin BS; Ha JW; Ware RS; Doan TN; Harley D
    Aust N Z J Psychiatry; 2023 May; 57(5):661-674. PubMed ID: 36700564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic medication and psychotherapeutic treatment of adults with intellectual disabilities (PROMPT-ID): a cross-sectional, epidemiological study in Saxony, Germany.
    Koch A; Dobrindt J; Schützwohl M
    BMJ Open; 2018 Dec; 8(12):e025947. PubMed ID: 30573492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characteristics of psychotropic drug use in institutionalized children and adolescents with mild intellectual disability.
    Scheifes A; de Jong D; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
    Res Dev Disabil; 2013 Oct; 34(10):3159-67. PubMed ID: 23886758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct service staff and their perceptions of psychotropic medication in non-institutional settings for people with intellectual disability.
    Christian L; Snycerski SM; Singh NN; Poling A
    J Intellect Disabil Res; 1999 Apr; 43 ( Pt 2)():88-93. PubMed ID: 10221788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study.
    Henderson A; Mcskimming P; Kinnear D; McCowan C; McIntosh A; Allan L; Cooper SA
    BMJ Open; 2020 Sep; 10(9):e036862. PubMed ID: 32912946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
    Schützwohl M; Voss E; Stiawa M; Salize HJ; Puschner B; Koch A
    Nervenarzt; 2017 Nov; 88(11):1273-1280. PubMed ID: 27638741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychotropic Prescribing Practices for Children and Adolescents with Intellectual Disabilities: A Cohort Study Using a Large-scale Health Insurance Database].
    Inoue Y; Okumura Y; Fujita J
    Seishin Shinkeigaku Zasshi; 2016; 118(11):823-833. PubMed ID: 30620838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge and expectations of direct support professionals towards effects of psychotropic drug use in people with intellectual disabilities.
    de Kuijper G; van der Putten AAJ
    J Appl Res Intellect Disabil; 2017 Dec; 30 Suppl 1():1-9. PubMed ID: 28467003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.